- Analysis: Drug pricing reform opponents win most pharma lobbying money https://www.reuters.com/business/healthcare-pharmaceuticals/capitol-hill-drug-pricing-reform-opponents-among-biggest-beneficiaries-pharma-2021-10-25/ 30 comments moderatepolitics
- Analysis: Drug pricing reform opponents win most pharma lobbying money https://www.reuters.com/business/healthcare-pharmaceuticals/capitol-hill-drug-pricing-reform-opponents-among-biggest-beneficiaries-pharma-2021-10-25/ 13 comments politics
Linking pages
- Pro-pharma Democrats kill bill to lower drug costs — advocates ask: “What did they get for that?” | Salon.com https://www.salon.com/2021/10/29/pro-pharma-democrats-bill-to-lower-costs--advocates-ask-what-did-they-get-for-that/?user_id=%2A%7CEMAIL%7C%2A 419 comments
- Blame Manchin and Sinema for the Delay on the Infrastructure Vote | The Nation https://www.thenation.com/article/politics/manchin-sinema-build-back-better/ 294 comments
- Prescription Drug Reforms Are Out Of The Spending Deal, At Least For Now | HuffPost Latest News https://www.huffpost.com/entry/biden-no-deal-on-prescription-drugs-failure-democrats_n_617a93e9e4b093143215050c 63 comments
Linked pages
Related searches:
Search whole site: site:www.reuters.com
Search title: Analysis: Drug pricing reform opponents win most pharma lobbying money | Reuters
See how to search.